Related Experiment Video
Updated: Feb 28, 2026

07:55
Isolating Myofibrils from Skeletal Muscle Biopsies and Determining Contractile Function with a Nano-Newton Resolution Force Transducer
Published on: May 7, 2020
7.7K
Dihydropyridine Receptor Inhibition Attenuates Force and Fiber Cross-Sectional Area Decrease in the Three-Day
Kristina A Sharlo1, Sergey A Tyganov1, Daria A Sidorenko1
1Myology Laboratory, Institute of Biomedical Problems (IBP), RAS, 123007 Moscow, Russia.
International Journal of Molecular Sciences
|February 27, 2026
Summary
Blocking the dihydropyridine receptor (DHPR) prevents skeletal muscle atrophy during unloading. This approach preserves muscle contractile function and cellular integrity by inhibiting detrimental signaling pathways.
Area of Science:
- Muscle physiology
- Cellular signaling
- Biochemistry
Background:
- Sarcolemma depolarization is an early effect of skeletal muscle unloading.
- Unloading may activate dihydropyridine receptors (DHPR), leading to calcium release and muscle atrophy.
Purpose of the Study:
- To investigate the role of DHPR in unloading-induced skeletal muscle atrophy.
- To evaluate the therapeutic potential of DHPR inhibition for preserving muscle function.
Main Methods:
- Rat soleus muscles were unloaded via hindlimb suspension for three days.
- Nifedipine, a DHPR calcium channel blocker, was administered.
- Muscle contractile properties, ATP, ROS, Ca2+ content, PGC1alpha mRNA, and Junctophilin-1 (JP1) were assessed.
Main Results:
- DHPR inhibition attenuated the decline in muscle contractile properties.
- Nifedipine prevented the accumulation of ATP, ROS, and Ca2+.
- DHPR blockade inhibited JP1 proteolysis and preserved PGC1alpha mRNA levels.
Conclusions:
- DHPR activation contributes to skeletal muscle atrophy during unloading.
- Inhibiting DHPR preserves muscle contractile function and cellular homeostasis.
- DHPR blockers represent a potential therapeutic strategy for inactive muscle preservation.

